Hollsteen
← Cerebras

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2023: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2024: −$967M · 10-Q 0001628280-26-044981 filed Jun 24, 2026Equity incl. NCI · FY2025: −$579M · 10-Q 0001628280-26-044981 filed Jun 24, 2026missing−579−967FY2016FY2025FY2021
$MEquity incl. NCI · FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2022: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2023: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · FY2024: −$967M · 10-Q 0001628280-26-044981 filed Jun 24, 2026Equity incl. NCI · FY2025: −$579M · 10-Q 0001628280-26-044981 filed Jun 24, 2026missing−579−967FY2020FY2025FY2023
FY2025
−579$M
All values (2)
PeriodValue ($M)Status
FY2025−579reported
FY2024−967reported
FY2016 – FY2023–missing (8 periods): No verified SEC value extracted, although the company reports this metric in other periods.

Show reported periods only · CSV with all sources · Technical ID: equity_total

More metrics for Cerebras

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
−$579M
Period
FY2025, ended Dec 31, 2025 · as of Dec 31, 2025 (balance as of date, not a sum)
Source
10-Q, filed Jun 24, 2026 · 0001628280-26-044981
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1−$579MJun 24, 202610-Q 0001628280-26-044981reported · confidence 1. · current